Background Image

Türkiye Cancer Institute

Comparison and Validation of FDA-Approved Genomic Profiling Results in Cancer Patients with Domestic NGS Kit

This strategic translational research project seeks to compare and validate the efficacy of a domestically developed next-generation sequencing (NGS) test kit against FDA-approved genomic profiling panels that are extensively utilized in oncological diagnosis and therapeutic decision-making. By establishing the clinical utility of the locally produced diagnostic assay, the initiative aims to enhance the sustainability, accessibility, and reliability of genomic testing infrastructure within the national healthcare system.